Ticker League

Estimates for MetLife (MET)

Analyst consensus revenue & EPS estimates for MetLife (MET) — Q2 2026. Compare the numbers and make your own prediction.

Consensus EPS · Q2 2026

$2.30

Consensus revenue · Q2 2026

$19.6B

Analysts

11

Expected report

Aug 5, 2026

After close
Upcoming earnings
Locks in 13 days 9 hours · AMC: Locks at 4:00 PM ET on report day
Revenue$19.6B$18.9B $20.5B
EPS$2.30$2.20 $2.42

What to watch

  • Analyst ratings: Mixed
Make your prediction

Analyst consensus

Based on estimates from 11 analysts.

  • Revenue$19.6B
  • EPS$2.30
  • EBITDA$2.1B
  • EBIT$1.9B
  • Net income$1.5B

Historical beat/miss

Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.

  • Q1 2026-2.1%+6.5%
  • Q4 2025-11.1%+6.6%

Estimate revisions

How analyst consensus estimates have changed over the past 90 days.

Collecting data

Revision trends appear once we have collected at least two daily snapshots for this period.

Community vs analysts

See how the TickerLeague crowd's forecast stacks up against Wall Street.

Be the first to predict

No community consensus for MetLife (MET) Q2 2026 yet. Make a prediction to start the crowd forecast.

Make your prediction

Analyst price target

Based on price targets from 6 analysts.

Low
$90.00
Consensus
$98.22
Median
$96.00
High
$105.00
Current
$93.27
Upside
+5.3%

Upside calculated vs most recent trading price of $93.27.

Analyst ratings

Consensus: Buy — based on 33 analyst ratings.

Buy 25Hold 8

24-month trend

Recent analyst actions

  • Jul 21, 2026JP MorganOverweight
  • Jul 13, 2026Keefe, Bruyette & WoodsOutperform
  • Jul 13, 2026Evercore ISI GroupIn Line
  • Jul 10, 2026JefferiesBuy
  • Jul 9, 2026Wells FargoOverweight
  • Jul 9, 2026MizuhoOutperform
  • Jul 8, 2026UBSBuy
  • Jul 7, 2026BarclaysOverweight
  • Jul 6, 2026Morgan StanleyOverweight
  • Jun 24, 2026Piper SandlerNeutral

Frequently asked questions